Newsroom - Opharmic Technology

Opharmic Achieves ISO 13485 Certification

We are thrilled to announce that Opharmic Technology (Opharmic) has successfully obtained the prestigious ISO 13485:2016 certification, validating our commitment to maintaining a robust quality management system. This achievement highlights our dedication to designing and developing cutting-edge ultrasound systems in the MedTech industry while adhering to the highest standards. ISO 13485:2016 certification holds global recognition […]

Iso Certification Photo Wb Cover

ALL

BUSINESS UPDATES

17/05/2023

Opharmic selected to be on 2022 Forbes Asia “100 to Watch” List

The Opharmic Team are extremely pleased to let you know that amongst over 650 submissions, we are selected to be on the prestigious list of Forbes Asia 100 to Watch in 2022!The recognition from Forbes Asia can’t come at a better time as we look forward to bringing you some big news here at Opharmic throughout the rest of 2022 and […]

Opharmic selected as the Winner of the 2021 APAC MedTech Innovator Competition

ALL

BUSINESS UPDATES

30/08/2022

Opharmic announce grant of Japanese patent covering novel MeticTouch ocular drug induction technology

The Managements of Opharmic are pleased to announce that the Japan Patent Office has granted the patent covering the MeticTouch ocular induction platform technology. Extensively covering the method, design, and applications of the novel drug delivery system, the MeticTouch platform offers exclusive opportunities to its partners by providing non-invasive delivery solutions to therapeutics at all […]

Opharmic announce grant of Japanese patent covering novel MeticTouch ocular drug induction technology

ALL

BUSINESS UPDATES

17/02/2022

NEWSROOM